Evidence map›Paper›PMID 31537986›Full record

ArticleEcancermedicalscience2019

Innovative approaches for cancer treatment: current perspectives and new challenges.

Carlotta Pucci, Chiara Martinelli, Gianni Ciofani

Abstract read
In one paragraph

Article in Ecancermedicalscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 291 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
291citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

291 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Application of virtual reality for supportive care in cancer patients: a systematic review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Exploring the determinants of health literacy and its effects on health-related outcomes in family caregivers of patients with cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Trial
  6. Trial
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. MnOPharmaceutics · 2026
    Article
  13. Review
  14. Article
  15. Review
  16. International journal of molecular sciences · 2026
    Article
  17. Review
  18. Review
  19. Article
  20. Review

231 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Carlotta PucciSmart Bio-Interfaces, Istituto Italiano di Tecnologia, 56025 Pisa, Italy.
Chiara MartinelliSmart Bio-Interfaces, Istituto Italiano di Tecnologia, 56025 Pisa, Italy.
Gianni CiofaniSmart Bio-Interfaces, Istituto Italiano di Tecnologia, 56025 Pisa, Italy.

Funding

European Research Council 709613
6 · The paper itself

Abstract

Every year, cancer is responsible for millions of deaths worldwide and, even though much progress has been achieved in medicine, there are still many issues that must be addressed in order to improve cancer therapy. For this reason, oncological research is putting a lot of effort towards finding new and efficient therapies which can alleviate critical side effects caused by conventional treatments. Different technologies are currently under evaluation in clinical trials or have been already introduced into clinical practice. While nanomedicine is contributing to the development of biocompatible materials both for diagnostic and therapeutic purposes, bioengineering of extracellular vesicles and cells derived from patients has allowed designing

Indexed as

cancerextracellular vesiclesgene therapyimmunotherapynanomedicinepathomicsradiomicstargeted therapythermal ablation

Identifiers

PMID31537986
PMCPMC6753017

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.